Related Experiment Video
Updated: May 11, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744
A Vislovukh1, G Kratassiouk, E Porto
1State Key Laboratory on Molecular and Cell biology, Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kiev 03680, Ukraine.
Background:
Eukaryotic translation elongation factor 1A2 (eEF1A2) is a known proto-oncogene. We proposed that stimulation of the eEF1A2 expression in cancer tissues is caused by the loss of miRNA-mediated control.
Methods:
Impact of miRNAs on eEF1A2 at the mRNA and protein levels was examined by qPCR and western blot, respectively. Dual-luciferase assay was applied to examine the influence of miRNAs on 3'-UTR of EEF1A2. To detect miRNA-binding sites, mutations into the 3'-UTR of EEF1A2 mRNA were introduced by the overlap extension PCR.
Results:
miR-663 and miR-744 inhibited the expression of luciferase gene attached to the 3'-UTR of EEF1A2 up to 20% and 50%, respectively. In MCF7 cells, overexpression of miR-663 and miR-744 reduced the EEF1A2 mRNA level by 30% and 50%. Analogous effects were also observed at the eEF1A2 protein level. In resveratrol-treated MCF7 cells the upregulation of mir-663 and mir-744 was accompanied by downregulation of EEF1A2 mRNA. Both miRNAs were able to inhibit the proliferation of MCF7 cells.
Conclusion:
miR-663 and miR-744 mediate inhibition of the proto-oncogene eEF1A2 expression that results in retardation of the MCF7 cancer cells proliferation. Antitumour effect of resveratrol may include stimulation of the miR-663 and miR-744 expression.
Insights
MicroRNAs miR-663 and miR-744 inhibit the proto-oncogene eukaryotic translation elongation factor 1A2 (eEF1A2), slowing cancer cell growth. Resveratrol may boost these miRNAs, contributing to its anti-cancer effects.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Eukaryotic translation elongation factor 1A2 (eEF1A2) is identified as a proto-oncogene.
- Cancer tissue studies suggest that loss of microRNA (miRNA)-mediated control contributes to elevated eEF1A2 expression.
Purpose of the Study:
- To investigate the role of specific miRNAs in regulating eEF1A2 expression.
- To explore the impact of miRNAs on cancer cell proliferation.
Main Methods:
- Quantitative PCR (qPCR) and Western blot were used to assess miRNA effects on eEF1A2 mRNA and protein levels.
- Dual-luciferase assays and site-directed mutagenesis of the EEF1A2 3'-UTR identified miRNA binding sites.
Main Results:
- miR-663 and miR-744 significantly inhibited luciferase expression linked to the EEF1A2 3'-UTR.
- Overexpression of miR-663 and miR-744 reduced eEF1A2 mRNA and protein levels in MCF7 cells.
- Resveratrol treatment led to increased miR-663 and miR-744 levels, correlating with decreased EEF1A2 mRNA and inhibited MCF7 cell proliferation.
Conclusions:
- miR-663 and miR-744 effectively inhibit the proto-oncogene eEF1A2, leading to reduced proliferation of MCF7 cancer cells.
- The anti-tumor effects of resveratrol may involve the upregulation of miR-663 and miR-744.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Leaky Scanning
MicroRNAs
MicroRNAs
Mitogens and the Cell Cycle
Improving Translational Accuracy

